Time:
All Today Tomorrow This Week This Month

Solutions for in vivo barriers to gene therapy vectors

Gene therapy to treat human disease has evolved from a relatively small group of dedicated scientists working on the fundamentals of gene delivery to mammalian cells, to a large industry capable of ex-vivo and in vivo gene therapy in patients.

05-18-2020 Casey Maguire, Ph.D.

Learn More

Determining the Optimal Mammalian Transient Expression to Boost Protein/Antibody Drug Discovery

Transient mammalian expression is a fast and economical tool to produce antibody (Ab) for a variety of research and preclinical applications.

05-14-2020 Dr. Tielin Zhou (Field Application Scientist, GenScript)

Learn More

Identification and Characterization of a Novel Biomarker for Cancer Therapy

Genomic instability is a universal hallmark of all cancers. Many of the most commonly used chemotherapeutic agents target this genomic instability by directly damaging the DNA, which results in tumour cell death.

05-12-2020 Joshua Burgess, Ph.D.

Learn More

Effective gene editing using the CRISPR RNP system: higher editing efficiency, lower off-target effects, and minimal cytotoxicity

The CRISPR/Cas9 system has made targeted gene editing easily accessible for research and therapeutic purposes.

05-07-2020 James Chon, Ph.D.

Learn More

CRISPR genome editing and its applications

Genome editing has always been a challenging area as a means to provide more efficient ways to create a meaningful change in the genome.

05-06-2020 Dr. Edward Wong, Field Application Scientist, GenScript

Learn More

Tips for Successful ELISA kit Development

Tips for Successful ELISA kit Development

04-29-2020 Dr. Pei Liu, Senior Scientist, GenScript

Learn More

< 17 18 19 20 21 22 23 24 25 26 27 > Total Pages 36